Iatrogenic sexual dysfunction in men - a practical algorithm for outpatient practice and a pharmacological context.

Area of Science:

• Pharmacology
• Urology
• Men's Health

Background:

• Drug-induced sexual dysfunction is a frequent, underreported adverse effect of chronic pharmacotherapy in men.
• Manifestations include reduced libido, erectile dysfunction (ED), ejaculatory, and orgasmic disorders.
• The link between medication and sexual dysfunction can be subtle, requiring careful assessment.

Purpose of the Study:

• To present a pragmatic, implementable algorithm for outpatient physicians.
• To integrate sexual health assessment with pharmacological analysis for drug-induced sexual dysfunction.
• To guide interventions, including the use of phosphodiesterase type 5 (PDE5) inhibitors for ED.

Main Methods:

• Development of a clinical algorithm for physicians.
• Integration of patient's sexual health evaluation with medication review.
• Consideration of drug causality, dose-dependence, interactions, and substitution strategies.

Main Results:

• The proposed algorithm facilitates systematic assessment of drug-induced sexual dysfunction.
• It aids in identifying potential causative agents and guiding therapeutic adjustments.
• Provides a framework for managing ED, including the appropriate use of PDE5 inhibitors.

Conclusions:

• A structured approach is crucial for diagnosing and managing drug-induced sexual dysfunction in men.
• Physicians can utilize this algorithm to improve patient care and address medication-related sexual side effects.
• Effective management can enhance quality of life for men undergoing long-term pharmacotherapy.